Yingzhen Du

机构：Chinese Center For Disease Control and Prevention, Chinese PLA General Hospital, Chinese General Hospital College of Nursing and Liberal Arts, National Clinical Research Center for Digestive Diseases · ORCID：0000-0003-3352-8824

发表论文 39 篇 · 总被引 3687 次 · h-index 14

代表论文

• Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality (2021 · International Reviews of Immunology · 被引 168)
• Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance (2025 · Journal of Nanobiotechnology · 被引 119)
• RIPK3 Induces Cardiomyocyte Necroptosis via Inhibition of AMPK‐Parkin‐Mitophagy in Cardiac Remodelling after Myocardial Infarction (2021 · Oxidative Medicine and Cellular Longevity · 被引 49)
• Lats2 deficiency protects the heart against myocardial infarction by reducing inflammation and inhibiting mitochondrial fission and STING/p65 signaling (2023 · International Journal of Biological Sciences · 被引 22)
• Nebulized inhalation of nintedanib-loaded biomimetic nano-liposomes attenuated bleomycin-induced interstitial lung fibrosis in mice (2024 · Nano Today · 被引 20)
• BCAP31 Alleviates Lipopolysaccharide-Mediated Acute Lung Injury via Induction of PINK1/Parkin in Alveolar Epithelial Type II Cell (2024 · Research · 被引 16)